Ana Isabel Barrientos
Research Subjects
Research Interests
Ana Isabel Barrientos has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Ana Girleza Múnera-Echeverri
Universidad Pontificia Bolivariana
2 shared publications - Carlos Ignacio Ponte-Negretti
Cardiometabolic Medicine Unit, La Floresta Medical Institute , Caracas
2 shared publications - Claudia Almonte
12CEMDOE Unidad de Cardiología, Santo Domingo, República Dominicana
2 shared publications - Daniel Piskorz
Cardiology Institute of the Rosario British Sanatorium, Rosario, Argentina
2 shared publications - Fernando Wyss
Cardiovascular Services and Technology of Guatemala –CARDIOSOLUTIONS, Guatemala
2 shared publications - Horacio Márquez-González
Hospital Infantil de México Federico Gómez
2 shared publications
Latest Publications
- Open Access
- 14 January 2026
- Published by Ubiquity Press, Ltd. in Global Heart
- Vol. 21 (1) , 81
Immunization and Cardiovascular Disease in Latin America. The CorVacc Study: Sub Analysis by Regions
Introduction: In Latin America, the mortality rate from influenza and pneumococcal disease has increased in recent years. Several challenges limit the implementation of vaccination strategies. These factors contribute to lower-than-expected immunization rates in Latin America. Objective: The objective of this sub-analysis of the Inter-American Registry of Influenza and Pneumococcal Vaccination (CorVacc) is to determine vaccination rates and analyze the factors that influence the North – Central America and Carribean Spanish Speaking (NCC); Andean region (AR) and South Cone (SCR). Methods: A cross-sectional survey of the general population was conducted in 19 Latin American countries. Adults aged 18 and older completed a 34-question online survey. Data were grouped into seven categories: demographic, socioeconomic, and non-demographic. Multivariate logistic regression comparisons were performed between regions to assess the association between vaccination rates and their explanatory variables. Results: Influenza, Pneumococcus and ≥3 doses of COVID-19 vaccination was received by 4,126 (45.18%) CAC, 3,576 (50, 13%) AR and 3,024 (62, 99%) SC; 5,904 (65, 09%) CAC, 5,162 (68, 9%) AR and 3,486 (72, 61%) SC; and 6,266 (68, 61%) CAC, 6,001 (80, 09%) AR and 2,892 (79, 99%), respectively. No association was detected between the regions and the likelihood of receiving the influenza vaccine: AR OR 0.94 (95% CI 0.84–1, 06; p = 0.33), CAC OR 0.81 (CI 0.80–1, 00; p = 0.053). On the contrary, a positive association was detected with Streptococcus pneumoniae vaccination: AR OR 1.12 (CI 1, 01–1, 24; p = 0.032), CAC OR 1.33 (CI 1, 20–1, 47; p < 0.001). A negative association was observed in CAC with COVID-19 ≥ 3 doses vaccination: OR 0.56 (CI 0, 65; p = 0.032; p < 0.001). Social, economic and confidence barriers were identified, but cardiovascular risk factors and comorbidities were not significantly associated with lower vaccination rates. Conclusions: Social, economic, and cultural, but not cardiovascular risk factor or disease variables in Latin American region could explain the lower-than-expected rates of vaccination and the differences observed between regions in vaccination frequencies.
- 14 January 2026
- Published by Ubiquity Press, Ltd. in Global Heart
- Vol. 21 (1) , 81
Open AccessImmunization and Cardiovascular Disease in Latin America. The CorVacc Study: Sub Analysis by Regions
Introduction: In Latin America, the mortality rate from influenza and pneumococcal disease has increased in recent years. Several challenges limit the implementation of vaccination strategies. These factors contribute to lower-than-expected immunization rates in Latin America. Objective: The objective of this sub-analysis of the Inter-American Registry of Influenza and Pneumococcal Vaccination (CorVacc) is to determine vaccination rates and analyze the factors that influence the North – Central America and Carribean Spanish Speaking (NCC); Andean region (AR) and South Cone (SCR). Methods: A cross-sectional survey of the general population was conducted in 19 Latin American countries. Adults aged 18 and older completed a 34-question online survey. Data were grouped into seven categories: demographic, socioeconomic, and non-demographic. Multivariate logistic regression comparisons were performed between regions to assess the association between vaccination rates and their explanatory variables. Results: Influenza, Pneumococcus and ≥3 doses of COVID-19 vaccination was received by 4,126 (45.18%) CAC, 3,576 (50, 13%) AR and 3,024 (62, 99%) SC; 5,904 (65, 09%) CAC, 5,162 (68, 9%) AR and 3,486 (72, 61%) SC; and 6,266 (68, 61%) CAC, 6,001 (80, 09%) AR and 2,892 (79, 99%), respectively. No association was detected between the regions and the likelihood of receiving the influenza vaccine: AR OR 0.94 (95% CI 0.84–1, 06; p = 0.33), CAC OR 0.81 (CI 0.80–1, 00; p = 0.053). On the contrary, a positive association was detected with Streptococcus pneumoniae vaccination: AR OR 1.12 (CI 1, 01–1, 24; p = 0.032), CAC OR 1.33 (CI 1, 20–1, 47; p < 0.001). A negative association was observed in CAC with COVID-19 ≥ 3 doses vaccination: OR 0.56 (CI 0, 65; p = 0.032; p < 0.001). Social, economic and confidence barriers were identified, but cardiovascular risk factors and comorbidities were not significantly associated with lower vaccination rates. Conclusions: Social, economic, and cultural, but not cardiovascular risk factor or disease variables in Latin American region could explain the lower-than-expected rates of vaccination and the differences observed between regions in vaccination frequencies.
- Open Access
- 5 December 2025
- Published by Ubiquity Press, Ltd. in Global Heart
- Vol. 20 (1) , 108
Immunization and Cardiovascular Disease in Latin America. The CorVacc Study: Results
Introduction: Immunization rates against influenza and pneumococcus in Latin America remain lower than expected, particularly in Andean region, Central America, Mexico, and Caribbean region. An incremental correlation between economic strata and educational level and vaccines uptake has been observed. This highlights the need for more comprehensive data to accurately characterize the current health landscape and develop strategies for improvement. Methods and Design: The Inter-American Registry of Influenza and Pneumococcal Vaccination (CorVacc Study) is a cross-sectional survey of the general population conducted across 19 Latin American countries. Adults aged 18 years and older completed a 34-question online survey. The pool was validated within the first 1000 responses. Data were grouped into seven categories: demographics, socioeconomic and educational level, cardiometabolic profile, cardiovascular interventions, medical follow-up and treatments, and COVID-19 vaccination status. Results: A total of 21,389 responses were obtained, distributed as follows: 8915 from the North, Central, and Caribbean region; 7492 from the Andean region; and 4801 from the Southern Cone region. Influenza vaccination rates were lower in the Andean region (OR: 0.62; 95% CI: 0.50–0.78), the Caribbean (OR: 0.30; 95% CI: 0.23–0.39), and Central America (OR: 0.59; 95% CI: 0.46–0.76) compared with the Southern Cone. Residing in Central America (OR: 3.06; 95% CI: 1.62–5.77) was associated with greater pneumococcal vaccination. The probability of being vaccinated against influenza was higher in men (OR: 1.3; 95% CI: 1.1–1.6) and in individuals with obesity (OR: 1.26; 95% CI: 1.13–1.40). COPD was associated with a lower probability of pneumococcal vaccination (OR: 0.51; 95% CI: 0.33–0.79). Conclusions: This study highlights the importance of targeted vaccination campaigns to improve coverage, particularly in regions with lower rates. It also underscores the need for enhanced education and awareness of the benefits of vaccination. Tackling barriers such as vaccine hesitancy and misinformation will be essential for raising vaccination rates and, ultimately, for reducing the burden of cardiovascular disease.
- 5 December 2025
- Published by Ubiquity Press, Ltd. in Global Heart
- Vol. 20 (1) , 108
Open AccessImmunization and Cardiovascular Disease in Latin America. The CorVacc Study: Results
Introduction: Immunization rates against influenza and pneumococcus in Latin America remain lower than expected, particularly in Andean region, Central America, Mexico, and Caribbean region. An incremental correlation between economic strata and educational level and vaccines uptake has been observed. This highlights the need for more comprehensive data to accurately characterize the current health landscape and develop strategies for improvement. Methods and Design: The Inter-American Registry of Influenza and Pneumococcal Vaccination (CorVacc Study) is a cross-sectional survey of the general population conducted across 19 Latin American countries. Adults aged 18 years and older completed a 34-question online survey. The pool was validated within the first 1000 responses. Data were grouped into seven categories: demographics, socioeconomic and educational level, cardiometabolic profile, cardiovascular interventions, medical follow-up and treatments, and COVID-19 vaccination status. Results: A total of 21,389 responses were obtained, distributed as follows: 8915 from the North, Central, and Caribbean region; 7492 from the Andean region; and 4801 from the Southern Cone region. Influenza vaccination rates were lower in the Andean region (OR: 0.62; 95% CI: 0.50–0.78), the Caribbean (OR: 0.30; 95% CI: 0.23–0.39), and Central America (OR: 0.59; 95% CI: 0.46–0.76) compared with the Southern Cone. Residing in Central America (OR: 3.06; 95% CI: 1.62–5.77) was associated with greater pneumococcal vaccination. The probability of being vaccinated against influenza was higher in men (OR: 1.3; 95% CI: 1.1–1.6) and in individuals with obesity (OR: 1.26; 95% CI: 1.13–1.40). COPD was associated with a lower probability of pneumococcal vaccination (OR: 0.51; 95% CI: 0.33–0.79). Conclusions: This study highlights the importance of targeted vaccination campaigns to improve coverage, particularly in regions with lower rates. It also underscores the need for enhanced education and awareness of the benefits of vaccination. Tackling barriers such as vaccine hesitancy and misinformation will be essential for raising vaccination rates and, ultimately, for reducing the burden of cardiovascular disease.